Breaking News
November 17, 2018 - Sexuality education before age 18 may reduce risk of sexual assault in college
November 17, 2018 - Lab Innovations 2018 confirmed as a major hit with visitors, exhibitors and speakers
November 17, 2018 - Largest parasitic worm genetic study hatches novel treatment possibilities
November 17, 2018 - People with rare cancers can benefit from genomic profiling, shows research
November 17, 2018 - NIH awards over $1.8 million to husband-and-wife doctors to test new breast cancer approach
November 17, 2018 - Four-in-one antibody used to fight flu shows promise in mice
November 17, 2018 - New approach allows pathogens to be starved by blocking important enzymes
November 17, 2018 - Higher body mass index could cause depression even without health problems
November 17, 2018 - Protein which plays role in sensing cell damage serves as new target to treat pulmonary hypertension
November 17, 2018 - FDA Approves Adcetris (brentuximab vedotin) in Combination with Chemotherapy for Adults with Previously Untreated Systemic Anaplastic Large Cell Lymphoma or Other CD30-Expressing Peripheral T-Cell Lymphomas
November 17, 2018 - ID specialist input improves outcomes for outpatient parenteral antimicrobial therapy
November 17, 2018 - UT Southwestern scientists selected to receive 2019 Edith and Peter O’Donnell Awards
November 17, 2018 - New clinical algorithm to help individuals manage type 2 diabetes when fasting during Ramadan
November 17, 2018 - Researchers identify LZTR1 as evolutionarily conserved component of RAS pathway
November 17, 2018 - Heart Disease Leading Cause of Death in Low-Income Counties
November 17, 2018 - Estrogen Levels Test: MedlinePlus Lab Test Information
November 17, 2018 - Research reveals link between immunity, diabetes
November 17, 2018 - Research shows how to achieve improved smoking cessation outcomes within California’s Medicaid population
November 17, 2018 - New study finds less understanding and implementation of patient engagement
November 17, 2018 - New shoe insole technology could help diabetic ulcers heal better while walking
November 17, 2018 - New method to extend cell division and immortalization of avian-derived cells
November 17, 2018 - Australian Academy of Science urges parents to vaccinate children against meningococcal disease
November 17, 2018 - Hot water treatment may help improve inflammation and metabolism in sedentary people
November 17, 2018 - Researchers produce 3D chemical maps of small biological samples
November 17, 2018 - Must Blood Pressure Rise Wth Age? Remote Tribes Hold Clues
November 17, 2018 - Noonan Syndrome
November 17, 2018 - Interventions to delay and prevent type 2 diabetes are underused, researchers say
November 17, 2018 - Hackathon prize winner seeks to remotely monitor patient skin conditions
November 17, 2018 - Research team identifies Ashkenazi Jewish founder mutation for Leigh syndrome
November 17, 2018 - Gene editing could be used to halt kidney disease in patients with Joubert syndrome
November 17, 2018 - Study uncovers link between gut disruption and aging
November 17, 2018 - Teens more likely to pick up smoking after exposure from friends and family
November 17, 2018 - Nicoya designate the Institute for Stem Cell Biology and Regenerative Medicine as the OpenSPR Centre of Excellence
November 17, 2018 - new horizon in dental, oral and craniofacial research
November 17, 2018 - How does poor air quality affect your health?
November 17, 2018 - New device can regulate children’s blood glucose more like natural pancreas
November 17, 2018 - Game-Changers in Western Blotting and Protein Analysis
November 17, 2018 - FDA announces new actions to limit sale of e-cigarettes to youth
November 17, 2018 - Warmer winter temperatures related to higher crime rates
November 17, 2018 - MCO places increasing emphasis on helping people find and access healthy food
November 17, 2018 - Group of students aim to improve malaria diagnosis using old smartphones
November 17, 2018 - Transplantation of feces may protect preterm children from deadly bowel disease
November 17, 2018 - Researchers explore whether low-gluten diets can be recommended for people without allergies
November 17, 2018 - New and better marker for assessing patients after cardiac arrest
November 17, 2018 - For 7-year-old with failing bone marrow, a life-saving transplant | News Center
November 17, 2018 - New first-line treatment for peripheral T-cell lymphoma approved by FDA
November 17, 2018 - Artificial intelligence could be valuable tool to help young victims disclose traumatic testimony
November 17, 2018 - Breakthrough in the treatment of Restless Legs Syndrome
November 16, 2018 - FDA Approves Keytruda (pembrolizumab) for the Treatment of Patients with Hepatocellular Carcinoma (HCC) Who Have Been Previously Treated with Sorafenib
November 16, 2018 - Eagle Books | Native Diabetes Wellness Program
November 16, 2018 - Patients with common heart failure more likely to have lethal heart rhythms
November 16, 2018 - How AI could help veterinarians code their notes | News Center
November 16, 2018 - Bias-based bullying does more harm to students than generalized bullying
November 16, 2018 - Researchers find first direct evidence that cerebellum plays role in cognitive functions
November 16, 2018 - Non-coding genetic variant plays key role in endothelial function and disease incidence
November 16, 2018 - EMA recommends first all-oral treatment to tackle deadly sleeping sickness
November 16, 2018 - Drug used to treat dizziness may slow down growth of triple-negative breast cancer
November 16, 2018 - AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides
November 16, 2018 - ‘Orphan’ RNAs make cancer deadlier, but potentially easier to diagnose
November 16, 2018 - Air Cube touches down at hospital | News Center
November 16, 2018 - CRISPR-based tool shown to enhance cell-based immunotherapy
November 16, 2018 - Mechanisms that govern HIV latency differ in the gut and blood, finds study
November 16, 2018 - Researchers unravel mystery of NPM1 protein in acute myeloid leukemia
November 16, 2018 - High school students less likely to select milk, fruit for lunch when fruit juice is available
November 16, 2018 - Football coaches with great emotional competence are more successful
November 16, 2018 - Researchers awarded $10 million grant to address root causes of asthma in Puerto Rico
November 16, 2018 - Personalized scheduling of radiotherapy using genetic data could reduce side effects
November 16, 2018 - American Cancer Society study links social isolation to higher mortality risk
November 16, 2018 - Health Tip: Manage Morning Sickness
November 16, 2018 - Long term exposure to road traffic noise linked with greater obesity risk
November 16, 2018 - Infant gut microbes altered by mother’s obesity may increase risk for future disease
November 16, 2018 - Immunotherapy combination and chemotherapy show encouraging results in Phase II acute myeloid leukemia study
November 16, 2018 - ACC Latin America Conference brings experts to discuss latest cardiovascular science
November 16, 2018 - Pooled analysis of Intersect ENT’s steroid releasing implants in patients after frontal sinus surgery to be published
November 16, 2018 - Expectations about pain intensity can become self-fulfilling prophecies
November 16, 2018 - NIH awards $3.4 million to UC researchers to study gastrointestinal lymphatic system
November 16, 2018 - Highlighting Advances in Bioengineering and Analytical Technologies with eBooks
November 16, 2018 - Scientist Dr David Taylor of MR Solutions is a finalist in the BMW i UK Tech Founder Awards
November 16, 2018 - Earlier treatment could help reverse autistic-like behavior in tuberous sclerosis
November 16, 2018 - Sucking your baby’s pacifier could improve their health
WHO revise treatment guidelines of lymphatic filariasis due to CWRU-led study

WHO revise treatment guidelines of lymphatic filariasis due to CWRU-led study

image_pdfDownload PDFimage_print

Researchers from Case Western Reserve University School of Medicine have shown that a single “cocktail” of three pill-based anti-parasite medications is significantly more effective at killing microscopic larval worms in people diagnosed with lymphatic filariasis, commonly known as elephantiasis, than other standard two-drug combinations previously used in the global effort to eliminate this infectious disease. A combination of all three drugs given simultaneously had never been tested until now. An estimated 120 million people in over 50 tropical and subtropical countries are infected with lymphatic filariasis and another 856 million people are at risk.

As a result of these findings, published in today’s issue of the New England Journal of Medicine, the World Health Organization has revised its treatment guidelines for preventive chemotherapy of lymphatic filariasis in numerous countries worldwide where current mass treatment regimens have been unsuccessful in achieving elimination or have not yet been started. Countries that plan mass drug treatment with this new regimen include Papua New Guinea (where the study was conducted), Haiti, Indonesia, Fiji, India, Samoa, Madagascar, Kenya, São Tomé and Príncipe, Zimbabwe, and Guyana.

The disease is characterized by grossly enlarged limbs and breast (elephantiasis) and massive swelling of the scrotum (hydrocele). Of those infected, an estimated 25 million men suffer from hydrocele and 15 million, mostly women, exhibit elephantiasis of the limbs and breast.

“Lymphatic filariasis has been targeted for global elimination by the WHO in arguably the largest mass drug administration program ever attempted for an infectious disease,” said the study’s lead author, Christopher L. King, MD, PhD, professor of international health, medicine, and pathology at Case Western Reserve University School of Medicine. “Our findings offer the promise of effectively banishing this disease from a long list of health threats facing people in many developing countries.” In 2000 the World Health Organization targeted lymphatic filariasis for global elimination by 2020.

Although strides have been made with the existing two drug regimens–a 32 percent reduction in the number people at risk for lymphatic filariasis globally has been achieved to date–countries with weaker health infrastructures have struggled with the requirement to deliver at least five annual rounds of mass drug treatment at a population coverage of 65 percent in order to achieve elimination. This new drug regimen promises to require fewer rounds of annual treatment because of its greater efficacy and, therefore, increases the potential of achieving global elimination. However, even with better drug regimens, elimination cannot be achieved if people living in areas where lymphatic filariasis is endemic fail to take the drugs. An important aspect of the elimination program going forward will be to assure better coverage at the population level.

Ivermectin (IVM), diethylcarbamazine (DEC), and albendazole (ALB) are all established anti-parasite medications. In the study of 182 participants conducted in Papua New Guinea, the researchers found that a single dose of a three-drug regimen of IVM, DEC and ALB resulted in a far greater sustained clearance of microscopic worms than a single dose of a two-drug regimen of DEC and ALB. The three-drug, single dose was as effective as the two-drug regimen administered once a year for three years. This finding is especially noteworthy because public health programs find it challenging to ensure people living in filariasis endemic areas take anti-parasitic drugs annually over five or more years.

“Lymphatic filariasis is a leading cause of permanent disability worldwide,” said the study’s senior author, James W. Kazura, MD, Distinguished University Professor and director of the Center for Global Health and Diseases at Case Western Reserve University School of Medicine. “In addition to its devastating physical ramifications, which often make it challenging to work and conduct normal daily activities, the gross disfiguration can have psychosocial consequences, such as being shunned by their communities.”

Lymphatic filariasis is a round worm infection related to the dog heart worm where adult male and female worms localize in the human body’s lymphatic system. The female worms release microscopic larvae (microfilaria) that circulate in the blood and which can be ingested by mosquitoes. Mosquitoes can then allow the development of infective larvae that can be transmitted to new hosts during the blood feeding. The larvae grow into adult threadlike worms that obstruct the human lymph system, causing major fluid retention and swelling in the arms, legs, breasts, and scrotum.

To date, 6.7 billion two-drug treatments have been administered to more than 850 million people in 66 countries at least once. For more than three decades, the pharmaceutical companies Merck Inc. and GlaxoSmithKline have donated the medications used to eradicate lymphatic filariasis. More recently Eisai Co. Ltd. in Japan has donated DEC.

Tagged with:

About author

Related Articles